Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
asm-024 (4 trials)
Asthma (Phase 2)
Lung Diseases, Obstructive (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Trials (4 total)
Trial APIs (1 total)